PLUS1
3.23
0.04 (1.25%)
0.04 (1.25%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Chimerix Inc | CMRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.04 | 1.27% | 3.19 | 3.12 | 3.275 | 3.25 | 3.15 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.11 | 3.30 | 0.19 | 5.76% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,542 | 553,189 | $ 3.19 | $ 1,764,832 | 1,831,134 | 1.19 - 4.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:33:41 | formt | 100 | $ 3.23 | USD |
Chimerix Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 197.56M | 61.93M | 47.93M | $ 12.52M | $ - | -1.95 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Chimerix News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/28/2020 | 08:00 | GlobeNewswire Inc. | Chimerix to Present at Jefferies Virtual Healthcare.. |
| 5/07/2020 | 08:35 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 5/07/2020 | 08:20 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/07/2020 | 07:00 | GlobeNewswire Inc. | Chimerix Reports First Quarter 2020 Financial Results and.. |
| 4/29/2020 | 07:00 | GlobeNewswire Inc. | Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT.. |
| 4/28/2020 | 16:30 | GlobeNewswire Inc. | Chimerix Receives FDA Clearance for Rolling Submission of.. |
| 4/28/2020 | 13:31 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CMRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.17 | 3.55 | 3.07 | 3.23 | 473,084 | 0.02 | 0.63% |
| 1 Month | 2.75 | 3.90 | 2.70 | 3.28 | 978,606 | 0.44 | 16.0% |
| 3 Months | 1.43 | 3.90 | 1.19 | 2.39 | 1,069,800 | 1.76 | 123.08% |
| 6 Months | 2.56 | 3.90 | 1.19 | 2.23 | 753,209 | 0.63 | 24.61% |
| 1 Year | 3.39 | 4.40 | 1.19 | 2.23 | 658,674 | -0.20 | -5.9% |
| 3 Years | 4.86 | 5.94 | 1.19 | 2.89 | 391,295 | -1.67 | -34.36% |
| 5 Years | 41.69 | 58.07 | 1.19 | 7.41 | 609,395 | -38.50 | -92.35% |
Chimerix Description
| Chimerix Inc is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The two clinical-stage development programs are dociparstat sodium (DSTAT) and brincidofovir (BCV). The DSTAT is a glycosaminoglycan compound derived from porcine heparin that has low anticoagulant activity but retains the ability to inhibit activities of several key proteins implicated in the retention and viability of AML blasts and leukemic stem cells in the bone marrow during chemotherapy. The BCV is an antiviral drug candidate in development as a medical countermeasure for smallpox. |
